Press Releases - Cardiol Therapeutics

Investor Resources

Contact Us

Investor ResourcesPress Releases

Press Releases

Press Release Cardiol Therapeutics Appoints Michael J. Willner to its Board of DirectorsSeptember 7, 2021

Press Release Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx™ for Acute MyocarditisAugust 24, 2021

Press Release Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”August 9, 2021

Press Release Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as ChairmanJuly 7, 2021

Press Release Cardiol Therapeutics Reports Results of 2021 Annual General and Special MeetingJune 30, 2021

Press Release Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDTJune 28, 2021

Press Release Cardiol Therapeutics Closes $22 Million Bought Deal OfferingMay 12, 2021

Press Release Cardiol Announces Upsize to Previously Announced Bought Deal Public OfferingMay 6, 2021

Press Release Cardiol Therapeutics Announces $15 Million Bought Deal Public OfferingMay 5, 2021